Project Grant RC2NS144286
- The National Institute of Neurological Disorders and Stroke awarded Emory University $618,523 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on September 1, 2026, for research on scalable, affordable artificial intelligence-driven clinical decision support for movement disorders. The project addresses misdiagnosis and access barriers in Parkinson's disease care, particularly the underdiagnosis of psychiatric symptoms and limited...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $428,218 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop subcellularly resolved spatial genomics approaches for studying axon regeneration. The research maps the nerve regenerative landscape by building a three-dimensional spatial single-cell transcriptomics atlas of dorsal root ganglia in mice, training a...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $577,611 on January 23, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate how cell-specific neural activity contributes to resting-state functional magnetic resonance imaging (rs-fMRI) patterns in the brain. The research develops and deploys simultaneous wide-field optical imaging (WOI) and rs-fMRI methodology to detect...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $234,750 on January 26, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate neuromodulation of somato-sympathetic postganglionic activity after spinal cord injury. The research develops animal models incorporating clinically analogous epidural spinal cord stimulation to understand how neuromodulation can restore autonomic function...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $547,750 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate human-specific mechanisms governing miR-124 regulation of neuronal development. The research focuses on microRNA biogenesis and function in the human brain, specifically examining how miR-124—the most abundant microRNA in brain tissue—controls spatiotemporal...
- Federal Grant Award Summary Emory University received a $430,375 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025 through June 30, 2027. The award funds research to elucidate the mechanisms of altered RNA transport dynamics caused by KIF1C (Kinesin-3 motor protein) mutations in heterospastic paraplegia type 58 (SPG58), a...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $534,557 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of Renshaw cells and recurrent inhibition during motor behaviors. The research examines how Renshaw cells—inhibitory interneurons within the spinal cord's output-regulating microcircuit—contribute to coordinated limb movements and motor control in...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $234,750 on May 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate NMDA receptor regulation of rapid synaptic scaling and spinal excitability in fragile X syndrome. The research will identify mechanisms controlling maturation of network excitability during neonatal development, with focus on how NMDA receptor blockade triggers...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $430,375 on June 22, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop x-ray dark-field imaging technology for carotid hemodynamic analysis using anisotropic iron oxide nanorods as contrast agents. The research addresses cerebrovascular disease assessment and plaque vulnerability prediction by advancing grating-based interferometric...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $540,901 on April 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate molecular mechanisms underlying dopamine signaling dysfunction in advanced Parkinson's disease. The research examines how striatal projection neurons become maladaptive during disease progression and why L-DOPA therapy loses efficacy over time. The work focuses...
The National Institute of Neurological Disorders and Stroke awarded Emory University $460,839 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to cultivate rigor in movement neuroscience research by aligning professional incentives with rigorous study design practices. Emory will establish community-focused programs to address the reproducibility crisis in movement neuroscience by creating incentives that prioritize rigorous practices over traditional quantifiable metrics such as publication counts or grant funding. The recipient will offer four core support mechanisms: a dedicated funding vehicle for investigator-initiated rigor activities; free consulting services to help laboratories plan and implement baseline rigor practices; free curriculum design for faculty to develop rigor educational modules for technical science courses; and a rigor-focused monthly journal club paired with an annual research prize evaluating scholarship based substantially on rigor components. Emory will engage an external evaluator to assess the efficacy of these incentive programs and will actively disseminate data on program effectiveness and lessons learned to build broader buy-in within the field. The award runs through August 31, 2029, with place of performance in Atlanta, Georgia. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $460.8k | 9/1/26 |